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Abstract
Objective: To briefly review the current understanding of the aetiology and
prevention of chronic diseases using a life course approach, demonstrating the life-
long influences on the development of disease.
Design: A computer search of the relevant literature was done using Medline-‘life
cycle’ and ‘nutrition’ and reviewing the articles for relevance in addressing the above
objective. Articles from references dated before 1990 were followed up separately. A
subsequent search using Clio updated the search and extended it by using ‘life cycle’,
‘nutrition’ and ‘noncommunicable disease’ (NCD), and ‘life course’. Several published
and unpublished WHO reports were key in developing the background and
arguments.
Setting: International and national public health and nutrition policy development in
light of the global epidemic in chronic diseases, and the continuing nutrition,
demographic and epidemiological transitions happening in an increasingly
globalized world.
Results of review: There is a global epidemic of increasing obesity, diabetes and other
chronic NCDs, especially in developing and transitional economies, and in the less
affluent within these, and in the developed countries. At the same time, there has
been an increase in communities and households that have coincident under- and
over-nutrition.
Conclusions: The epidemic will continue to increase and is due to a lifetime of
exposures and influences. Genetic predisposition plays an unspecified role, and with
programming during fetal life for adult disease contributing to an unknown degree. A
global rise in obesity levels is contributing to a particular epidemic of type 2 diabetes
as well as other NCDs. Prevention will be the most cost-effective and feasible
approach for many countries and should involve three mutually reinforcing strategies
throughout life, starting in the antenatal period.
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The burden of chronic diseases is rapidly increasing
worldwide. It has been calculated that, in 2001, chronic
diseases contributed approximately 46% of the global
burden of disease1. About half of these deaths are
attributable to cardiovascular diseases; obesity and
diabetes are also showing worrying trends, not only
because they already affect a large proportion of
the population, but also because they have started to
appear earlier in life. Based on current estimates, the
proportion of the burden of chronic diseases is expected
to increase to 57% by the year 2020, at enormous
healthcare and other costs for societies and govern-
ments2,3. Already, 79% of deaths attributable to chronic, or
noncommunicable, diseases are occurring in developing
countries, predominantly in middle-aged men4. Cardio-
vascular diseases are now commoner in India, and also in
China, than in all economically developed countries in the
world added together4.
Much of the early research into cardiovascular diseases,
and hence the subsequent preventive activities, was
carried out on middle-aged and older western men.
However, there has been considerable work in recent
years which led to a recognition of gender and age issues
in chronic disease prevention and control5–7. More
recently, there has been a growing awareness of the
exploding noncommunicable diseases (NCDs) epidemic
in the developing countries and countries in transition.
It is now clear that the development, treatment and
particularly prevention of the NCDs are applicable to all
populations, although regional and national differences
such as age of onset, continue to vary. This may be due to
the rapid rate of the societal changes in countries
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undergoing the epidemic now, as opposed to the more
gradual evolution of the NCDs in the last century in
European and North American countries8.
Chronic diseases or NCDs are, themselves, a series of
overlapping and complicated disease entities, some of
which markedly amplify the likelihood of developing a
further disease, and in that sense become risk factors
themselves, e.g. obesity and diabetes. The so-called
metabolic syndrome is a clustering of risk factors including
hyperglycemia, hypertension, dyslipemia, mediated by
insulin resistance and resulting in a range of end-point
diseases beginning with type 2 diabetes. Increasingly
common in the developing countries, nearly a quarter of
US adults have been identified as having the syndrome9.
Other combinations occur, meaning that the person at risk
of one chronic disease is likely to have an underlying
disorder predisposing to other diseases. These risk factors
are indicative of disease processes progressing throughout
the life course. There is increasing evidence that these
risks begin in fetal life and continue into old age. Adult
chronic disease, therefore, reflects cumulative differential
lifetime exposures to damaging physical and social
environments. To quote Kuh and Ben-Shlomo10, such an
approach ‘does not draw false dichotomies between adult
lifestyle and early life influences, or between biological
and social risk factors’.
This paper reviews the development of chronic disease
and its prevention and control over the life course with
some emphasis on the developing countries and countries
in transition. The number of people in the developing
world with diabetes will increase by more than 2.5 times
(from 84 to 228 million) in 20257. Many of the communities
are already bearing a double burden of disease—both
undernutrition in infants, children and women, often in the
same household, and overnutrition in the adults, especially
in older women11,12. Both forms of malnutrition†, and the
resulting chronic disease patterns of stunting obesity,
cardiovascular diseases, hypertension and cancer, and
other NCDs, occur predominantly in the more disadvan-
taged and poorer sectors of the society. Economic
disparities are virtually increasing in virtually all countries,
as well as internationally, and can be expected to worsen
the incidence and outcomes of NCDs, especially for the
more disadvantaged13. Many studies show a relationship
between health and the relativity of income between the
rich and poor in a given society, so this increased ‘social
disadvantage’ may disproportionately affect the incidence
of chronic (and other) diseases, as well as affect the access
to treatment. The disadvantage will also be reflected in the
uptake, or more usually lack of uptake, of health
promoting behaviours amongst the poorest sections of
the society.
Taking a life course perspective has great potential and
several challenges. It is now generally accepted that the
risk of many NCDs is not just determined by risk factors in
mid-adult life, but begins in childhood or adolescence,
and likely even earlier, i.e. during fetal development14. A
WHO Report7 identifies three reasons for the current
interest in this approach: (i) the increasing evidence of
‘tracking’ of conventional risk factors from childhood to
adulthood; (ii) the evidence for ‘programming’ as a
potential model of disease aetiology with, in particular,
‘the fetal origins of adult disease’ hypothesis; and, (iii)
emerging evidence to indicate that some early risk factors
may act across generations. It is also necessary to consider
both ‘critical’ and ‘sensitive’ periods throughout the life
course where exposures are deterministic or especially
powerful in predisposing to, or lessening, the risk of
disease. To add to this complexity, it is necessary to
recognize and include the relative role of, and interaction
between, earlier and later influences on risk factors, as
well as the environments in which populations live and
which help to shape the total life experience of health.
The same WHO report identifies four theoretical and
overlapping models from Ben-Shlomo and Kuh15 that
explains ways in which such factors may act to cause
chronic diseases over the life course:
1. Critical period model—where an insult during a
specific period of growth or development has a lasting,
lifelong effect on physical functioning or structure that
results in disease later on;
2. Critical period influences with later modifiers of their
effects, i.e. the later factors modify an earlier-incurred
risk;
3. Accumulation of risk with correlated results—where
risk factors cluster in socially or biologically patterned
ways, and hence raise the risk of disease through
social and/or biological chains or pathways of risk
where one adverse (or protective) experience will
tend to lead to another adverse (or protective)
experience in a cumulative way; and,
4. Accumulation of risk with independent and uncorre-
lated results—where separate and independent risk
factors at each stage of life combine to raise disease
risk.
One further issue becomes apparent, that much of the
evidence available is from research and experience in
developed/industrialized countries. There is more limited
research available in some countries in transition such as
Brazil16, and quite limited data from developing countries.
Some important work has been published from China and
India which is particularly helpful.17
The life course
This paper will review the processes and environmental
and societal influences that cause or modify the risk of
chronic diseases developing and progressing throughout
†The term malnutrition is used to express both under- and over-
nutrition in this paper.
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the life course (Fig. 1), with an emphasis on prevention.
For convenience, the paper discusses five stages of the life
course, such as fetal development and the maternal
environment, infancy and childhood, adolescence, adult-
hood, and ageing and older people. Although distinct in
themselves, they merge imperceptibly into one another
with different influences becoming more or less important
over the course of one’s life. The term ‘life course’ is used
by the WHO to emphasize the elderly and that it is not
solely a reproductive ‘life cycle’.
Other factors essential for the discussion are the social
and economic changes that are operating on a scale and at
a speed unprecedented in history, resulting in rapid
changes in dietary and physical activity patterns world-
wide. These rapid global changes are the major causes of
the increasing global NCD epidemic.
The process of modernization and economic transition
has seen most of the countries of the world move towards
industrialization with national economies based on trade
within a global market. This has brought about a number
of improvements to the standard of living and services
available to people throughout the world. However,
it has also had a number of negative consequences that
have directly and indirectly led to deleterious dietary
and physical activity patterns that contribute to the
development of a number of NCDs. Indeed, some changes
in the industrialization of food production have con-
tributed to the consumption of a diet higher in fat
(particularly saturated fat) and protein content and lower
in complex carbohydrates.
The decline in the demands for physical activity seen
with modernization, and other societal changes, usually
lead to a more sedentary lifestyle. Motorized transport,
mechanized equipment, and labor-saving devices both in
the home and at work have replaced physically arduous
tasks. In addition, changing societal structures have also
led to an increasing proportion of the population working
in service, clerical and other professional occupations that
demand considerably less energy expenditure than the
physically demanding manual work of more traditional
societies.
At the same time there are many other social,
economic and demographic challenges to countries,
including environmental degradation and pollution,
emerging and re-emerging diseases such as HIV/AIDS,
malaria, TB and BSE, as well as the continuing scourge
of wars and their victims, including refugees, and
displaced children and adults. In developing policies to
confront these changes, countries are powerfully
influenced by international and global forces. Among
them the factors that need to be addressed in a
progressive and coherent manner are: global trade and
the effects of world trade agreements; business practices
of multinational food and drug companies; the role of
mass media on lifestyles; ethical issues; and, issues of
human rights4,18.
Fetal development and the maternal environment
The four relevant factors in fetal life are: (i) intra-uterine
growth retardation (IUGR); (ii) premature delivery of a
Fig. 1 Life course: the proposed causal links. Source: adapted from ACC/SCN, 2000
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normal growth-for-gestational-age fetus; (iii) overnutrition
in utero; and, (iv) intergenerational factors. Intergenera-
tional factors will be addressed later. There are recognized
limitations in using low birth weight to capture the range
of potentially important exposures in utero19. For
example, a finding in the study of the Dutch famine was
that of an association between high blood pressure and
exposure to famine in early gestation even though this was
not seen to be linked with low birth weight7. It is useful to
keep in mind that the following epidemiological findings
of metabolic and structural programming have been found
experimentally in animals such as rodents and some
studies of primates in a way consistent with the disease
susceptibility observed in human studies20.
Intra-uterine growth retardation
There is considerable evidence, mostly from developed
countries, that IUGR is associated with an increased risk of
coronary heart disease (CHD), stroke, and diabetes7,14.
Evidence from historical cohorts or retrospective studies
has shown clear associations between retarded fetal
growth (as evidenced by small size at birth) and risk of
CHD21–23, diabetes24–28, stroke21,29,30.
While low birth weight is the indicator commonly
used, due to its relative convenience and availability,
research using more specific indices of fetal growth have
shown important differences in the strength of associ-
ations between disease and different kinds of fetal or
IUGR31. Further evidence for an association between
IUGR and later chronic disease has been looked for in
the ‘famine studies’ from populations, such as those of
the Dutch famine (from 1944 to 194532) and of the
Russian famine in the Leningrad siege (from 1941 to
194433) during World War II. The Dutch study showed
that exposure to famine in early gestation is associated
with an increased risk of heart disease, but the Russian
study showed no such effect. In the developing world,
only a limited number of studies, e.g. India, have
examined this relationship34. An association between low
birth weight and CHD was found in one35 but in the
other, subsequent diabetes was found to be associated
with obesity (higher ponderal index) rather than low
birth weight36.
Blood pressure in childhood has also been found to be
associated with low birth weight in cohort studies from
both the developed and developing world, including
Chile, China, DR Congo, Guatemala, India, Jamaica, South
Africa, UK, and Zimbabwe7. Fewer studies, including the
two ‘famine studies’, have not found this relationship and
in Hong Kong greater length at birth was associated with
higher blood pressure37. As noted before, the association
of low birth weight with childhood BP may depend on
the type of growth retardation or impairment experienced
in utero.
While there appears to be good, although not
conclusive, associative evidence for reduced fetal growth
and increased risk of metabolic syndrome in middle life38,
the association of fetal growth to impaired glucose
tolerance (IGT) or dyslipidemias is not clear7, and studies
have found conflicting results. The Dutch famine study
showed a significant association between the exposure to
famine in early pregnancy (not related to lower size at
birth) and a more diverse lipid profile (higher LDL:HDL
ratio)39. In neither the Dutch nor the Russian studies was
there a significant association between exposure to famine
in utero and adverse HDL or TG levels33. Evidence from
the developing countries has been more supportive of an
association, e.g. China40. In India, a link was found
between low birth weight and adverse total serum
cholesterol and LDL-cholesterol levels in 8-year-old
children, highest in those with high fat mass41, and in
Jamaica, between total cholesterol levels and low birth
weight in 6–16-year-olds42.
An association between IUGR and IGT appears stronger
with a consistent association between small size at birth
and IGT in adulthood in historical cohort studies and in
China, India and South Africa7. Law et al.43 found that low
birth weight was associated with blood pressure at the
early age of 3. As will also be suggested later, it may not be
the low birth weight per se but rather a pattern of growth,
e.g. restricted fetal growth followed by very rapid
postnatal catch-up growth, that is important in these
underlying disease pathways44.
There is consistent evidence that high systolic blood
pressure in adulthood is associated with retarded fetal
growth (as measured by low birth weight)45–47. It is not
known, however, if this association mediates the link
between IUGR and CVD7. A recent meta-analysis has
questioned this apparent relationship, citing possible
methodological problems48 and concluding that birth
weight is of little importance to blood pressure levels in
later life. Nevertheless, there is supportive evidence that
comes from both developed and developing countries,
e.g. China40 and South Africa49.
Furthermore, there appears to be an interacting
effect between obesity or gained weight enhancing the
risk of CHD or diabetes associated with impaired fetal
growth, and there may be a similar effect for blood
pressure. In the Swedish study, the effect of low birth
weight on high blood pressure, increased with rising adult
body mass index (BMI), and the association of current
BMI to blood pressure was enhanced in those with low
birth weight50.
Premature delivery with normal growth-for-
gestational age
There are important nutritional and developmental
outcomes of prematurity, particularly depending on the
degree of early delivery. However, there has not been
animal or human work to suggest a linkage with later
development of chronic disease, although presumably a
proportion of the low birth weight infants in many of the
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studies showing such a relationship, were outcomes of
prematurity rather than fetal retardation. Nevertheless,
apart from this context, this category of low birth weight
will not be considered further.
Overnutrition in utero
Large size at birth (macrosomia) is also associated with an
increased risk of diabetes and CVD21,51. In India, and in
contrast to the above, among adults (and in contrast to the
relationship found among children) an association was
found between IGT and high ponderal index (i.e. fatness)
at birth36. In Pima Indians, a U-shaped relationship to birth
weight was found, whereas no such relationship was
found among Mexican Americans51,52. Higher birth weight
has also been related to an increased risk of breast and
other cancers10.
Infancy and childhood
Ideally, one would like to consider neonates, infancy,
young childhood and the ‘school-aged’ child as separate
stages, as early available evidence suggests that there may
be subtly different influences during each of these phases,
at least for some risk factor development7. However, there
does not appear to be enough evidence to do so at
present, and so infancy and childhood will be considered
together, and differentiation noted when relevant. Breast-
feeding is also considered in this section. Retarded growth
in infancy and childhood can be reflected in (i) failure to
gain weight, and (ii) failure to gain height, while (iii)
excessive gain in both weight or height (‘crossing the
centiles’) also appears to be a factor in later chronic
disease incidence, and then (iv) other factors, such as
growing up in a disadvantaged socioeconomic environ-
ment will also be noted.
Breastfeeding
There is increasing evidence that among term and pre-
term infants, breastfeeding is associated with significantly
lower blood pressure levels in childhood53,54. Singhal
et al.54 have shown that consumption of formula instead of
breast-milk in infancy also increases diastolic and mean
arterial blood pressure in later life. Nevertheless, studies
with older cohorts36 and the Dutch famine study55 have
not identified such associations. Evidence on the effect of
breastfeeding on dyslipidemias is conflicting. There is
also evidence suggesting a lower risk of developing
obesity56–59 and which may be directly related to length of
exclusive breastfeeding and may not become evident until
later in their childhood60. Some of the discrepancy may be
explained by socioeconomic and maternal education
factors confounding the findings.
Data from most, but not all, observational studies of
term infants have generally suggested adverse effects of
formula consumption on the other CVD risk factors (as
well as blood pressure), but little information is available
from controlled clinical trials61. Nevertheless, the weight of
current evidence indicates adverse effects of formula milk
on CVD risk factors, which is consistent with observations
among older adults who were fed formula as infants61,62.
The risk for several chronic diseases of childhood and
adolescence (type 1 diabetes, celiac disease, some
childhood cancers, and inflammatory bowel disease)
have also been associated with artificial infant feeding and
short term breastfeeding63. There are, of course, other
more immediate and long term developmental reasons to
promote breastfeeding, both for the child’s and the
mother’s sake64.
Postnatal growth in weight
An association between low growth in early infancy (low
weight at 1 year) and an increased risk of CHD, has also
been described, irrespective of size at birth65,66. This
would support a role, only from developed country
research at this point, for the importance of immediate
postnatal factors in shaping disease risk. Infant growth
rates in Bangladeshi infants, most of whom had chronic
intrauterine undernourishment and were breast-fed,
showed similar growth rates to breast-fed western infants,
but catch-up growth was limited and weight at 12 months
was largely a function of weight at birth67.
In a study of 11–12-year-old Jamaican children, blood
pressure levels were found to be highest in those with
retarded fetal growth and greater weight gain between the
ages 7 and 1168, and similarly in India41. Low birth weight
Indian babies have been described as having a character-
istic poor muscle but high fat preservation, the so-called
‘thin–fat’ babies. This phenotype persists through post-
natal period and is associated with increased central
adiposity in childhood, that is linked to the highest risk of
raised blood pressure and disease risk34,69,70. In most
studies, the association between the low birth weight and
high blood pressure has been found to be particularly
strong if adjusted to current size (BMI) suggesting the
importance of weight gain after birth71, although it has
been questioned whether this is an appropriate adjustment
to make48.
Relative weight in adulthood and weight gain have also
been found to be associated with increased risk of cancer
of the breast, colon, rectum, prostate, and other sites72.
Whether there is an independent effect of childhood
weight is difficult to determine, as childhood overweight is
usually continued in to adulthood. Relative weight in
adolescence was significantly associated with colon
cancer in one retrospective cohort study73. In a study
following up an earlier survey of Boyd-Orr in the late
1930s, after accounting for confounding effects of social
class, it was found that for both sexes, there was a
significant positive relationship between childhood
energy intake and adult cancer mortality74. The recent
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review by the International Agency for Research into
Cancer in Lyon, France concluded there was clear
evidence of a relationship between early, and later,
onset of obesity and cancer risk75.
Childhood growth in height
Short stature (including measures of childhood leg
length), a reflection of socioeconomic deprivation in
childhood76, is associated with an increased risk of CHD
and stroke, and to some extent, diabetes28,77–82. Given
that short stature, and specifically short leg-length are
particularly sensitive indicators of early socioeconomic
deprivation, their association to later disease very likely
reflects an association between early undernutrition and
infectious disease load83,84.
Height serves partly as an indicator of socioeconomic
and nutritional status in childhood. As has been seen, poor
fetal development and poor growth during childhood
have been associated with increased cardiovascular
disease risk in adulthood, as have indicators of unfavor-
able social circumstances in childhood. Conversely, a high
calorie intake in childhood may be related to an increased
risk of cancer in later life74. Height is inversely associated
with all cause, CHD, stroke, and respiratory disease
mortality among men and women85.
On the other hand, height has been used as a proxy of
usual childhood energy intake, which is particularly
related to body mass and the child’s activity. However, it is
clearly an imperfect proxy because when protein intake is
adequate (energy appears to be important in this regard
only in the first 3 months of life), genetics will define adult
height72. Protein, particularly animal protein, has been
shown to have a selective effect in promoting height
growth, and it has been suggested that childhood obesity
is related to excess protein intake. Overweight or obese
children tend to be in the upper percentiles for height.
Height has been shown to be related to cancer mortality at
several sites, including breast, uterus, and colon72. The risk
of stroke is increased by accelerated growth in height
during childhood45. As accelerated growth has been
linked to development of hypertension in adult life, this
may be the mechanism (plus an association with low
socioeconomic status).
Other factors in childhood
There is a higher prevalence of raised blood pressure with
low socioeconomic status86–92, in adults but also in
children coming from low socioeconomic backgrounds,
although the latter is not always associated with higher
blood pressure later in life7. Blood pressure has been
found to track from childhood to predict hypertension in
adulthood, but with stronger tracking seen in older ages of
childhood and in adolescence93.
The higher blood pressure in childhood (in combi-
nation with other risk factors) causes target organ and
anatomical changes associated with cardiovascular risk,
including reduction in artery elasticity, increased ventri-
cular size and mass, hemodynamic increase in cardiac
output and peripheral resistance7,94,95. High blood
pressure in children is strongly associated with obesity,
in particular central obesity and clusters and tracks with an
adverse serum lipid profile (especially LDL-cholesterol)
and glucose intolerance94,96,97. There may be some ethnic
differences although these often seem to be explained by
differences in BMI. A retrospective mortality follow-up of a
UK survey of family diet and health (1937–1939) identified
significant associations between childhood energy intake
and mortality from cancer74.
The presence and tracking of blood pressure in children
and adolescents occurs against a background of unhealthy
lifestyles, including excessive intakes of total and saturated
fats, cholesterol and salt, inadequate intakes of potassium,
and reduced physical activity, often accompanied by high
levels of television viewing7. In adolescents, habitual
alcohol and tobacco use contributes to raised blood
pressure98,99.
Adolescence
There are three critical issues in adolescence impacting on
chronic diseases: (i) development of risk factors during
this period; (ii) the tracking of risk factors throughout life;
and, in terms of prevention, (iii) the development of
healthy, or conversely, unhealthy habits that tend to stay
throughout life.
Development of risk factors
It was recognized during the Vietnam war that US recruits
killed in warfare, although apparently fit young men,
already had clear evidence of atherosclerotic damage to
their blood vessels. There has been a trend towards
overweight and obesity in adolescence (with high levels of
unhealthy eating and physical inactivity patterns) through-
out the world. This is true in all industrialized countries,
especially in low socioeconomic groups, and increasingly
true of transitional economies100. Television viewing has
been specifically implicated101,102.
Raised blood pressure is usually measured in mid or
later life and is a main risk factor for cardiovascular
diseases, especially stroke and CHD103. Some long term
cohort studies (Harvard Alumni, Chicago Heart Associ-
ation Detection Project, Glasgow University Students
Study) have shown that high blood pressure in
adolescence or young adulthood is strongly related to
later risk of stroke or CHD, independently of blood
pressure in mid-life104–108. In other words, risk of CVD,
through high blood pressure, already starts well before
middle age7, and this clearly has repercussions for
prevention and treatment.
While mean blood pressure levels have decreased over
the past decades in industrialized countries109–111, in
developing countries they appear to be rising—usually
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along with GNP112. One study documenting such adverse
trends shows them particularly in the younger popu-
lation113. High blood pressure tracking from childhood to
adulthood is related to the onset of early atherosclerosis as
shown in the Bogalusa Heart Study95,98. Early high blood
pressure is particularly found to be a problem in Sub-
Saharan Africa, consonant with the higher rates of stroke
and susceptibility to hypertension observed among
African and African-American populations114,115.
Tracking of risk factors
Clustering of risk factor variables already occurs in
childhood and adolescence and is associated with
atherosclerosis in young adulthood, and thus risk of later
cardiovascular disease98,116,117. As noted earlier, this
clustering has been described as the metabolic or
‘syndrome X’—the clustering of physiological disturbances
associated with insulin resistance including hyperinsuline-
mia, IGT, hypertension, elevated plasma triglyceride and
low HDL-cholesterol118,119. Raised serum cholesterol both
in middle age and in early life are known to be associated
with an increased risk of disease later on. The Johns
Hopkins precursor study showed serum cholesterol levels
in adolescents and youngwhitemaleswere strongly related
to subsequent risk of CVD mortality and morbidity120.
Although the risk of obesity does not apparently
increase in adults who were overweight at 1 and 3 years
of age, the risk rises steadily thereafter, regardless of
parental weight121. Tracking has also been reported in the
transitional country of China, where overweight children
were 2.8 times as likely to become overweight adolescents
(and conversely underweight children were 3.6 times as
likely to remain underweight as adolescents). The authors
found that parental obesity, and underweight, the
children’s initial BMIs, dietary fat intake, and family
income helped predict tracking and changes122. However,
in a British prospective cohort study, little tracking from
childhood overweight to adulthood obesity was found
when using a measure of fatness (percentage body fat for
age) that was independent of build. The authors also found
only children obese at 13 years to have an increased risk of
obesity as adults, and that no excess adult health risk from
childhood or adolescent over weight was found123.
Interestingly, they found the thinnest children tended to
have the highest adult risk at every level of adult obesity.
The real concern about these early manifestations of
chronic disease, besides that they are occurring earlier and
earlier, is that once developed they tend to track in that
individual throughout life. On the more positive side, there
is also evidence that they can be corrected, but overweight
and obesity are notoriously difficult to correct after
becoming established, and there is the established risk of
overweight during childhood persisting into adolescence
and adulthood101. A recent meta-analysis by Parsons
et al.124,125 showed that the later the weight gain in
childhood and adolescence, the greater the persistence.
More than 60% of overweight children have at least
one additional risk factor for cardiovascular disease, such
as raised blood pressure, hyperlipidemia, or hyperinsuli-
nemia, and more than 20% have two or more risk factors101.
Developing habits leading to NCD development
during adolescence
It seems increasingly likely that there are widespread
effects of early diet on later body composition, physiology
and cognition61. Such observations ‘provide strong
support for the recent shift from defining nutritional
needs for prevention of acute deficiency symptoms to long
term prevention of morbidity and mortality’61. It is
recognized that increased birth weight increases the risk
of obesity later, but children with low birth weights tend to
remain small into adulthood101,126. However, in industri-
alized countries there have been only modest increases in
birth weights, so the increased levels of obesity described
earlier must reflect environmental changes101.
The ‘obesogenic’ environment appears to be largely
directed at the adolescence market, making healthy choice
that much more difficult. At the same time, exercise
patterns have changed and considerable parts of the day
are spent sitting at school, in a factory, or in front of a TV
screen or a computer. Raised blood pressure, IGT and
dyslipidemia are also associated in children and adoles-
cents with unhealthy lifestyles, such diets containing
excessive intakes of fats (especially saturated fats), refined
carbohydrates, cholesterol and salt, inadequate intake of
fiber and potassium, along with a lack of exercise7.
Physical inactivity and smoking have been found to
independently predict CHD and stroke in later life7.
It is increasingly recognized that unhealthy lifestyles do
not just appear in adulthood but drive the early
development of obesity, dyslipidemia, high blood
pressure, IGT and associated disease risk. In many
countries, perhaps most typified by the USA, in the last
30 years changes in family eating patterns and the
consumption of fast foods, pre-prepared meals and
carbonated drinks, have taken place101. Likewise, the
amount of physical activity has been greatly reduced both
at home and at schools, and in transport.
Adulthood
The three critical issues in adulthood are: (i) to what extent
do risk factors continue to be important in the
development of the chronic diseases; (ii) to what extent
will modifying them make a difference to the emergence
of disease; and, (iii) the role in risk factor reduction and
modification in secondary prevention and treatment in
those with disease. A recent WHO/FAO Expert Consul-
tation on diet, nutrition and the prevention of chronic
diseases, devoted to reviewing the evidence127 in a life
course approach demonstrated the importance of the
adult phase as a key phase in life—both in terms of
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expression of most chronic disease but also as a critical
time in the preventive reduction of risk factors, and as well
as increasingly effective treatment128. Modifying risk
factors and the impact of doing this is discussed under
the discussion of interventions. As this paper is addressing
primary prevention, secondary prevention and treatment
is not further discussed here, but have been identified as
major factors in the decline of chronic disease mortality in
more affluent countries128.
Adult risk factors
The most firmly established associations between CVD or
diabetes and factors in the life span are those between
diseases and the major known ‘adult’ risk factors—tobacco
use, obesity, physical inactivity, cholesterol, high blood
pressure, and alcohol127,129. The factors confirmed to lead
to increased risk of CHD, stroke and diabetes are: high
blood pressure for CHD or stroke130,131; high cholesterol
(diet) for CHD132,133, and tobacco use for CHD134. Other
associations are robust and consistent though have not
necessarily been shown to be reversible7: obesity, physical
inactivity for CHD, diabetes and stroke135–137; and, heavy
and/or binge drinking for CHD and stroke134,138. Most of
the studies are from developed countries, but supporting
evidence from developing countries is beginning to
emerge, as for example in India139.
There is also evidence of adult tracking. There is a
strong association between the serum cholesterol level,
e.g. measured in early adult life in men and cardiovascular
disease in mid-life, as well as total mortality120. Similarly,
the Chicago Heart Association Detection Project in
Industry found that in young men, blood pressure above
normal was significantly related to increased long term
mortality due to CHD, CVD, and all causes107. Their
conclusion was that population-wide primary prevention,
early detection, and control of higher blood pressure are
indicated in the young adult and on. The majority of cases
of adult onset type II diabetes are characterized by the
early development of insulin resistance with compensa-
tory true hyperinsulinemia140.
In developed countries, low socioeconomic status is
associated with higher risk of cardiovascular disease and
diabetes141. As in the affluent Western countries, there
appears to be an initial preponderance of CVD among the
higher socioeconomic groups, e.g. China142, which then is
presumed will progressively shift to the more disadvan-
taged sectors of society7, with some evidence this is
already happening, especially in low income women, e.g.
Brazil16 and South Africa143 and is in transition in countries
such as Morocco144.
The evidence is strong in adults, more so in men, as to
the risk factors in the development of chronic disease, but
also their role in secondary prevention and treatment.
However, the known risk factors have been calculated
to account for only about half of the known risk, and
so presumably other factors such as genetics and
programming make up much of the rest. However, a
recent article by Magnus and Beaglehole145 have been
able to account for most of the NCD epidemic, using the
known risk factors. Likewise, apparent anomalies are
deceptive: most men at apparently low visible risk (e.g.
slim, never smoked, etc.) who die prematurely, have
poorer risk profiles on other less visible risk factors, and
vice versa for men of high visible risk who survive146.
Other factors are being continually recognized or
proposed. These include the role of high levels of
homocysteine, the related factor of low folate, the role
of iron147 and others. From a social sciences perspective,
Losier148 has suggested that socioeconomic level is less
important than a certain stability in the physical and social
environment, and an individual’s sense of understanding of
his/her environment and of control over the course and
setting of his/her own life that is induced by this stability,
that appear to be most important as determinants of health.
Marmot149 and others have demonstrated the impact of the
wider environment and societal and individual stress on
contributing to the development of chronic disease.
Ageing and older people
There are three critical issues in the chronic diseases in the
later part of the life cycle: (i) most chronic diseases will be
manifested in this later stage of life; (ii) there is an absolute
benefit for ageing individuals and populations in changing
risk factors and adopting health-promoting behaviours
such as healthy diets and exercise; and, (iii) the need to
maximize health and quality of life by avoiding or delaying
preventable disability. Along with the societal and disease
transitions has been a major demographic shift. Conse-
quently what is defined as elderly, is very different from
the middle of last century, when 60 years of age and above
often exceeded the average life expectancy, especially in
industrialized countries.
Despite fears of increasing longevity leading to longer
periods of disability, there is increasing evidence that the
main burden of disability, is most often seen in those over
85 years and increasingly confined to the last year of
life150,151. In the US, statistically significant declines in
chronic disability prevalence rates were observed in those
over 65 years between 1982 and 1989152.
Chronic diseases in later life
Most chronic diseases present at this time of life would be
the result of interactions of multiple disease processes as
well as more general losses in physiological func-
tions152,153. Cardiovascular disease peaks at this period,
as does type 2 diabetes and cancer. While still a problem,
obesity becomes, on a population basis, less of a problem,
and in populations where weight is not increased
throughout adult life, hypertension may actually decrease.
Some cancers, e.g. breast, may occur earlier in life.
Nevertheless, the main burden of chronic diseases is at this
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stage of life and needs to be addressed. It is particularly of
concern to governments observing demographic trends,
especially in countries with rapidly declining birth rates,
and who foresee a greatly increased financial burden of
prolonged life but increased prevalence, especially as
health care for chronic diseases can be frighteningly
expensive. In other countries, less affluent, there is also a
concern about the double burden of disease (both under-
and over-nutrition) and the cost of treating chronic
diseases, often with low health budgets154,155.
These are concerns that need to be addressed, and
factual information provided to societies and policy
makers. However, recent analyses in some developed
countries such as Australia, suggest the concern is
overplayed, and that it is unlikely to be the health crisis
often portrayed, and that, with a calculated increase in
expenditure of only 0.54% due to ageing, ‘is not likely to
create significant problems in the future’156. As has been
pointed out in a recent editorial, there has been virtually
no attention to this issue in the developing countries157.
Whereas the burden of chronic diseases are definitely
greater in the elderly, the other advantages of seniority, in
terms of experience, knowledge and guidance are
generally uncosted variables that all countries, and
especially those with limited educated work force, can ill
afford not to use maximally151.
On the other hand, those suffering from these NCDs will
often be those who are most influential (at least in the first
phase of the disease transition) and will slant health care
investment towards the establishment of expensive
treatment and diagnostic facilities. There is considerable
evidence that primary prevention (and probably second-
ary prevention) is cost-efficient and of proven effective-
ness158. Now that the epidemic has moved into the less
affluent populations, the emphasis on treatment facilities,
disadvantages those who cannot afford them, not least in
the most affluent countries such as the USA. Thus, the most
important aspect to promote is: that intervening to effect
lifestyle change and reduce prevalence of risk factors in
later life, is extremely cost-effective. As the elderly
population vastly increases throughout the world, inter-
ventions, of proven effectiveness, will have an impact on a
greater and greater number of people. Not only that, the
improved health will result in enhanced further pro-
ductivity, as well as less dependency, and less spent on
health and institutional costs. This great cost benefit is also
very immediate and will be addressed again later.
Changing behaviours in older people
In the 1970s, it was thought that, in epidemiological terms,
risks were not significantly increased after certain late ages
and, therefore, that there was no benefit in changing
habits, e.g. dietary habits after 80 years of age159 as there
was no epidemiological evidence that changing habits
would affect mortality, or even health conditions, among
older people. There was also a feeling that people ‘earned’
some unhealthy behaviours simply because of reaching
‘old age’. Then, there was a more active intervention phase
when older people were actively encouraged to make
changes in their diet that probably were overly rigorous
for the expected benefit. More recently, older people are
being encouraged to eat a healthy diet, as large and as
varied as possible while maintaining weight, and
particularly to continue exercise153,158. Liu et al.160 have
reported an observed risk of incident atherosclerotic
disease among older women that was approximately 30%
less in women who ate 5–10 servings of fruits and
vegetables per day (cf. 2–5 servings/day). It is our
contention that, on a population basis, because elderly
patients have a higher cardiovascular risk they are more
likely to gain from risk factor modification161.
Although this age group have received relatively little
attention for primary prevention, the acceleration in
decline caused by external factors is generally reversible at
any age151. Interventions aimed at supporting the
individual and promoting healthier environments will
often also lead to increased independence in older age.
Maximizing quality of life in old age
The dramatic changes in fertility and mortality rates during
the 20th century has led to a rapidly ageing world in the
21st century. One of the big questions then becomes: are
we living healthier as well as longer lives, or are our added
years accompanied by disabilities and generally poor
health? The wider public perception appears to be that
healthcare personnel are there to make old peoples’ lives
miserable by getting them to give up everything they
might enjoy, urging them to be more active and so on.
However, there is increasing evidence of the positive
effects of exercise, at virtually all levels, for both mental
and physical health. Stress and depression are reduced
and lack of appetite stimulated, by appropriate exer-
cise163. Likewise, being mobile to undertake daily
activities of living, subjective feelings of well-being, and
economic security are all seen as among the most
important contributors to quality of life in older people
(at least in western and Asian populations)150. As has been
seen, rates of disability are actually continuing to decrease
in US elderly populations (despite increasing overweight)
and there are data indicating this is likely happening in
other industrialized countries152.
Interactions between early and later factors
throughout the life course
In addition to the evidence on independent associations of
IUGR, infancy and adulthood factors with later disease,
there are very suggestive indications that the interaction
between some of these early and later factors may lead to a
particularly high risk of chronic disease.
Low birth weight, followed by subsequent adult obesity,
has been shown to impart a particularly high risk of
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CHD164,165, as well as diabetes25. Risk of IGT has been
found to be highest in those who had low birth weight but
who subsequently became obese as adults25. A similar
effect has been seen in India where the raised risk of
insulin resistance and dyslipidemia was linked to the
central obesity driven by the distinct thin–fat phenotype
of IUGR Indian babies34,69,70,164.
In addition to the effect already mentioned of later
obesity, there is evidence to suggest an interaction
between small size at birth and accelerated growth in
height in raising risk of disease, e.g. in Finnish46 and
Swedish studies50, in adolescents as well as in younger
children. Several studies have demonstrated an interaction
between rapid catch-up growth in weight and IUGR in
increased risk of disease, e.g. in Finland where the highest
risk of CHD or metabolic syndrome, for both men and
women, was found to be associated with this
sequence22,27,66. The precise period in which increased
growth may increase risk of later disease is currently
unclear, although has major public health ramifications.
While there is limited evidence to demonstrate an
impact with height, Forsen et al.23 in Finland found that
short length at birth followed by enhanced growth in
height that resulted on average in tall height, was found to
be associated with an increased risk of CHD in women (as
opposed to tallness in girls with a longer birth weight who
showed a lower risk). Likewise, and also from Finland,
increased stroke risk for men and women was shown to be
associated with small birth size at birth, followed by
accelerated growth in height to reach average levels later
in childhood45,46. In the Indian subcontinent children
studied, there was some suggestion of a mediating effect
of height gained postnatally; the highest insulin levels
were found in children who had low birth weight but had
subsequently grown tall at 8 years, and highest yet in those
who had short parents41. This again may signal more the
importance of the postnatally gained weight or height, as
opposed to simply the low birth weight.
Conversely there is consistent evidence of higher risk of
CHD, stroke, and probably adult onset diabetes with
shorter stature. This could be working through a variety of
mechanisms, e.g. short stature as a marker for early
childhood deprivation, nutritional deprivation with infec-
tious disease load, psychosocial deprivation, socioeco-
nomic deprivation, low fetal growth, and genetic
influences (suggesting an intergenerational link).
Obesity, in particular abdominal obesity in adults, is one
of the main risk factors for CHD, stroke and diabetes165.
The adverse effects in adults of obesity are influenced by
degree of overweight, location of body fat, central obesity,
magnitude of weight gain and sedentary life style166.
Obesity in childhood and adolescence is already related to
risk of later CHD or diabetes165,167. Furthermore, if obesity
in childhood persists into the adult years, the morbidity
and mortality is greater than if the obesity developed in
the adult168. The question might be which is more
important—obesity gained in adulthood, or in childhood
and adolescence? It may be that the earlier onset also
means longer periods of insulin resistance, where it
appears to enhance risk associated with adult obesity169.
Willet and others have demonstrated evidence of added
importance of weight gain in the decade before the
disease was manifested170.
It has been suggested that the apparent role of weight
gained in mediating the link between IUGR and disease
risk is indicated by the fact that most studies find a
significant link or strong link only after adjustment for
current weight or BMI7. This has led some to suggest that
these linkages are about postnatal growth, more than low
birth weight, and that it is the importance of the magnitude
of centile crossing on later health that is important, and
that treating current BMI status as a confounder is missing
the point71.
There are four (not mutually exclusive) interpretations
of the above interactions—which have also been seen to
be linked with raised blood pressure, dyslipidemia and
IGT7:
1. Accelerated growth in weight or height could in itself
have negative consequences in terms of later diseases
developing;
2. The difference in size between birth and the later
growth and size with respect to established norms may
be most important—with greater difference related to
greater risk71;
3. An underlying susceptibility induced by impaired
early growth is revealed or activated by subsequent
obesity, i.e. obesity is particularly harmful in those
with early growth retardation; and,
4. The impaired fetal growth itself, (perhaps due to
placental insufficiency), may be a factor rather than the
effect of postnatal growth, that underlies the increased
risk of disease50.
While the particular interpretation may depend on the
specific disease or risk factor concerned, each indicates
the importance of an adequate postnatal nutritional
environment in bringing to the fore a risk associated
with fetal growth retardation7. To some extent, the actual
explanation will not alter the public health attention to
reducing and modifying risk factors, and advice to the
individual. It may, however, give greater emphasis to
addressing poverty, the environment and women’s health
and nutrition. While increased attention to postnatal
growth is equally self-evident, it is perhaps, even more
challenging171.
Clustering of risk factors throughout the life course
IGT and an adverse lipid profile are seen already in
childhood and adolescence, where they typically appear
clustered together with higher blood pressure and relate
strongly to obesity, and in particular central obesity.
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This has been observed in the Bogalusa Heart Study, the
Young Finns study and in Japan94,97,172,173. There may be
ethnic differences with more adverse levels of triglycerides
and HDL-cholesterol in children of European extraction
and a weaker relationship of obesity to dyslipidemia in
girls of African origin94. Ethnic differences in risk factors
have also been identified in some Asian populations, e.g.
between Caucasian populations and Chinese, Indian, and
Japanese174,175. Raised blood pressure, IGT and dyslipi-
demia also tend to be clustered in children and
adolescents with unhealthy lifestyles and diets. Lack of
exercise, and increased television viewing, and in older
children and adolescents, habitual alcohol and tobacco
use also contribute to raised blood pressure and the
development of other risk factors in early life7. Much the
same, factors continue to act throughout the life course.
As has been seen, obesity and overweight throughout
the life course appears to mediate or enhance the risk of
disease or risk factor prevalence associated with retarded
fetal growth. The important question is whether IUGR
enhances the risk of obesity itself. The evidence is
conflicting and difficult to interpret7. Although studies
have found a relationship between small size at birth and
central adiposity164, this is usually only found after
adjustment of current size41,176, and it is questioned as to
whether it is appropriate to do this71. In Guatemalan adults
it has been demonstrated very clearly that there is a
relationship between waist:hip ratio and per cent fat
according to degree of stunting in childhood, adjusted for
adult age, socioeconomic status and so on, including BMI;
and quite clearly those adults most severely malnourished
stunted in childhood have higher waist:hip ratios177.
However, it is important to keep in mind that most studies
find a consistent, often linear, positive relationship of BMI
with birth weight176.
From the perspective of older populations, a life course
perspective allows one to see health differences among
populations, social classes etc. as resulting from an
accumulation of material disadvantages that reflect widely
differing economic and social life circumstances178. The
clustering of risk factors, and disease outcomes in later life,
represents the result of interactions of multiple disease
processes throughout life, as well as more general losses in
physiological functions such as some decline in immune
function152.
Intergenerational effects
Young girls who grow poorly become stunted women and
are more likely to give birth to low-birth weight babies
who are then likely to continue the cycle by being stunted
in adulthood and so on179. Maternal birth size has been
demonstrated in Guatemala to be a significant predictor of
a child’s birth size even after controlling for gestational
age, sex of child, socioeconomic status, and maternal age,
height, and pre-pregnant weight180. During the Dutch
Famine, women who had been in utero in the last third of
pregnancy gave birth to children with lower birth weights
than normal, thus projecting the effect of the famine into
the next generation171.
The review by Aboderin et al.7 describes the evidence of
intergenerational transmission of CVD risk associated with
fetal growth in humans. Low birth weight in offspring has
also conversely been found to relate to parental
cardiovascular mortality181,182. While the mechanisms
remain unclear, animal models provide evidence of such
intergenerational transmission7. However, such relation-
ships appear to be very complex as, e.g. in one Norwegian
study that showed an impact of maternal age on risk of
type 2 diabetes among children, which increased with
rising birth order, but not in first-born children, but
actually decreased with mothers under 30 years183.
There are clear indications of intergenerational factors
in obesity such as parental obesity, maternal gestational
diabetes, and maternal birth weight. Maternal birth weight
and risk of blood pressure show low maternal birth weight
to be associated with higher blood pressure levels in the
offspring, independent of the relation between the
offspring’s own birth weight and blood pressure184.
Several strands of evidence link IGT and fetal growth as
being transmitted intergenerationally7. Maternal gesta-
tional diabetes leads to large birth weight leading to
gestational diabetes in the offspring, and greater risk of
subsequent diabetes185. This risk of maternal gestational
diabetes is a clear intergenerational effect with increased
risk of hyperglycemia in utero resulting in increased risk of
IGT in the offspring, and this effect has been demonstrated
to be transmissible from one generation to the next26. In
the Pima Indians, exposure to maternal gestational
diabetes is associated with a higher risk of IGT in the
offspring, as well as higher risk of their developing
gestational diabetes, independently of the offspring’s
weight185. Evidence from other populations indicates that
the risk of developing gestational diabetes mellitus is
enhanced by maternal obesity176, and short stature186,187.
Using a 1958 British longitudinal cohort study, Parsons
et al.124 concluded that maternal weight or body mass
largely explained the association between birth weight and
adult BMI and may be a more important risk factor for
obesity in the child than birth weight. They further suggest
that intergenerational associations between the mother’s
and her offspring’s BMI seem to underlie the ‘well
documented association between birth weight and BMI’124.
Unhealthy lifestyles, in particular smoking, have a direct
effect also on the health of the next generation, e.g.
smoking during pregnancy and low birth weight, and the
increased risk of children’s diseases such as respiratory
disease. A recent study from the UK demonstrated that
maternal smoking during pregnancy is also a risk factor for
early adult onset diabetes in their off-spring188. Smoking
during pregnancy may represent another important
determinant of metabolic dysregulation in offspring.
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It was also noted that cigarette smoking as a young adult
was also independently associated with an increased risk
of subsequent diabetes. A strong inverse relation between
infants’ birth weights and mothers’ mortality from
cardiovascular disease has been described, possibly
representing intergenerational influences on birth weight
and cardiovascular risk181.
The adoption of unhealthy behaviours by children and
adolescents has been shown to be heavily influenced by
massive marketing and media pressures, which are
reinforced through peer pressure, as well as through
parents’ own health behaviours such as physical inactivity
and their diet7,189. Socio-economic status plays a major
role, probably throughout the life course but certainly in
adulthood, although different relationships are found in
different populations and the nature and extent of the
association varies depending on cohort, gender, race, life
trajectories and stage in the epidemiological transition
process of those involved7. The social gradient of
unhealthy lifestyles in developing countries, just as that
of the biological risk factors, is generally assumed to be
opposite to that in developed countries, i.e. unhealthy
diets, physical inactivity and smoking are assumed to be
higher in more affluent, urban ‘westernized’ urban
populations. While this is generally true,190 the rate of
shift to less well-off sections of all societies is now
increasingly rapid—far swifter than the rate that occurred
in the industrialized countries8.
Interventions throughout the life course
The evidence presented demonstrates that risk factors
must be addressed throughout life course. However, the
important corollary to that, is whether it is actually
possible to reduce or modify these same risk factors and
behaviours using a life course approach?
The evidence is clear for adults, especially in affluent
males in developed countries where there has been
extensive experience. There is, however, no evidence that
changing maternal nutrition, and thus impacting on birth
weight, has been shown, as an intervention, to have a
subsequent impact on later chronic disease outcomes of
the offspring. Likewise, while there is some evidence of
the possibility of changing risk factors and behaviours in
children and adolescents, the impact has been shown on
risk factors rather than chronic disease outcomes. With
older people, there is a limited experience and
documentation, although with some encouraging evi-
dence of falling disability levels in US populations. Clearly,
there are tremendous logistical and epidemiological
challenges to getting the evidence basis needed. However,
the existing evidence suggests that it may not be
unreasonable to extrapolate to older children and
adolescents from the adult experience, and the data
suggest that there is a definite place to intervene in older
populations, at least up to 80 years.
However, the whole point of a life course approach is to
look at people more holistically (Fig. 2). Clearly, there are
many other reasons to improve the quality of life of the
very old, such as the increasing independence that good
diet and appropriate exercise are likely to bring. Likewise,
one does not need to invoke the likelihood of reduced or
delayed chronic disease in their offspring to promote the
best diet and health possible to pregnant women.
Attention to postnatal growth increasingly appears to be
critical but more complex. If an infant has been born with
some degree of IUGR, should we not then recommend
catch-up growth for fear of encouraging chronic diseases
later? Several studies have described associations between
higher birth weight (or other early growth indices) and
later ovarian, prostate and breast cancer191. However,
there are other reasons, such as those to do with resistance
to infectious disease, and later intellectual development
and improved productivity, to suggest that maximizing
growth potential, without shifting into overweight,
remains an intervention objective.
It is important to emphasize the point that it is primary
prevention and moving population profiles that are being
Fig. 2 Scope for NCD prevention—a life course approach. Source: adapted from Aboderin et al.7
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suggested. Individual change, especially related to obesity
is notoriously difficult, especially in terms of sustainability.
It has been said that the ever increasing levels of
overweight and obesity in the industrialized countries,
and now globally, shows a singular failure of focusing on
personal behaviour189. Nevertheless, The Nurses’ Health
Study showed that the effect of a combination of lifestyle
practices among women adhering to lifestyle guidelines
involving diet, exercise, and not smoking, was associated
with a very low risk of CHD192. Calculating from women
defined as low-risk, 82% of the coronary events in the
cohort might have been prevented if all women had been
of the same low-risk profile192. This work was not,
however, evidence of change, but of what would happen
if all women adhered to certain very healthy lifestyle
choices.
However, there are studies where actual change has
taken place, e.g. in physical activity162, and also persuasive
evidence from diabetes reduction193. Other evidence and
experience shows that it is possible to influence
communities and nations194–198 although the suitability
of this approach in developing countries has been
questioned199,200. Mann has suggested that the declining
rates of CHD in many affluent societies and the steady
global increase in type 2 diabetes mellitus, suggest
differing risk and/or protective factors worldwide for the
two diseases, but with the epidemic of obesity clearly a
factor in the dramatic rise in type 2 diabetes prevalence128.
The importance of a low saturated fat diet in lowering
cholesterol levels in children has been demonstrated in a
randomized, controlled trial amongst Finnish children201.
Primary care-based interventions when targeted properly
can help prevent obesity in children from a very young
age202, and because children generally spend so much
time in school, school based interventions are import-
ant202. Singapore has successfully controlled, and even,
reduced, childhood obesity rates203. Almost three decades
ago the Finns successfully implemented the community-
based North Karelia project197. More recently, Tuomilehto
et al.193 demonstrated that lifestyles can reduce the risk of
progression to diabetes by a striking 58% over 4 years. In
this case, each person received individual counseling
aimed at reducing weight, improving diet and increasing
physical activity, which may limit its transferability to less
affluent settings, and perhaps sustainability204. However, it
graphically demonstrates the potential of intervening and
prevention. Two earlier studies from China205 and from
Sweden206 had shown similar results but with less
randomized methods207. The recent study by the US
National Institutes of Health has added further convincing
evidence208.
Other trials and population studies have shown up to
80% of cases of CHD and up to 90% of type II diabetes
could potentially be avoided through changing lifestyle
factors, and about one third of cancers could be avoided
by eating healthily, maintaining normal weight, and
exercising throughout the life span127,192,209,210. The
contribution of diet to risk of cancer in Developing
Countries is lower, perhaps around 20%210. Likewise, long
term reduction in serum cholesterol concentration by 10%,
which can be achieved by moderate dietary change,
lowered the risk of IHD by 50% at age 40, falling to 20% at
age 70211.
However, there is much general agreement that for
interventions to have a lasting effect on the risk factor
prevalence and health of societies, more than health
education and health promotion are needed. Changing or
modifying the environment in which these diseases
develop is essential, and there is some evidence, e.g.
Mauritius and Poland where changes in tariffs and taxes
have had positive, if not always intended, effects127.
Conversely, changes in dietary patterns, the influence of
advertising and the globalization of diets, and widespread
reduction in physical activity have generally had negative
impacts in terms of risk factors, and presumably
subsequent disease. Reversing current trends will,
according to Nestle and Jacobson189, amongst many
others, ‘require a multifaceted public health policy
approach as well as considerable funding’. For the latter,
they suggest revenues from small taxes on selected
products that supply ‘empty’ calories such as soft drinks,
or that reduce activity such as cars189.
It is clear from all the above that risk of disease is
influenced by factors at all stages of the life course; that life
course influences are disease specific, but that there is
considerable overlap of risk factors, outcomes and
influences; and that life course impacts on disease are
population specific—reflecting social, economic, cultural,
nutritional and probably ethnic differences. It is also clear
that primary prevention at the individual, community and
national level can be effective in modifying risk factor
prevalence in adults. There are examples of successful
primary prevention programmes in many countries in
reducing mortality and morbidity due to CHD through risk
factor modification, so that deaths from cardiovascular
diseases have declined quite dramatically in the industri-
alized countries over the last three decades or so2,110,212.
Some recent trials examining changes in risk factors have
cast doubts on the effectiveness of these multiple risk
factor interventions in their present form for all
populations213. The workload on primary care providers
such as general practitioners should also not be under-
estimated214.
Government policy has an essential role in producing/-
facilitating a conducive economic and legal environment
for health change to happen effectively. But, as is also
clear, there are obvious other good reasons, such as cost
savings and personal well-being, to intervene, and more
broadly to promote, and facilitate healthy diets and
physical activity, and to ensure that governments and
others, help provide environments in which such healthy
choices are made easy. Shaw et al.178 call for changes in
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the tax structure, strengthening of health and other
services, improved equity in service delivery and
increasing payments through pensions, disability and
social assistance, as necessary to lessen the differences in
outcomes of chronic diseases over the life course. The
high importance of such approaches is that they will
impact on all stages of the life course and society in
general. Societal shifts towards healthy behaviours tend to
act on portions of the population less influenced and able
to make personal change—the socially disadvantaged,
adolescents and the elderly. Such shifts impact on all the
population, including those hard to reach, such as
adolescent mothers, and is thus an essential component
of interventions addressing chronic disease in societies.
Conclusions
From all the above, it is clear that, although there is a vast
volume of scientific evidence addressing a life course
approach to chronic disease prevention and control, the
final picture is still not complete, and even sometimes
contradictory. However, from the available evidence, it is
possible to state the following:
. unhealthy diets, physical inactivity and smoking are
confirmed risk behaviours;
. the biological risk factors of hypertension, obesity and
dyslipidemia are firmly established as risk factors for
CHD, stroke and diabetes;
. globally, risk factor trends are rising, especially obesity,
and in the developing countries particularly, smoking;
. the major biological risk factors emerge and act in early
life, and continue to have a negative impact throughout
the life course;
. they can continue to effect the health of the next
generation;
. an adequate and appropriate postnatal nutritional
environment is important; and,
. interventions are effective but must extend beyond
individual risk factors and continue throughout the life
course.
The most significant risk factors in terms of the life course
are diet, physical activity and smoking. However, the
effects of global transition and changing environments are
critical and also need to be addressed. Very often the
environmental and societal factors are modifiable, but
require concerted community action and governmental
support and commitment, as well as global action and
partnerships. Without such societal and broader political
change, it will be difficult to create an enabling
environment for many lifestyle changes at the individual
level—and it will increasingly be the most disadvantaged in
all societies who bear the brunt of this epidemic of chronic
diseases, and whose risk factors multiply and worsen one
another. It is likely this article has underemphasized the
enormous impact of socioeconomic status215 because it is
generally, but probably wrongly, not seen as modifiable
and of concern to public health practitioners216.
Furthermore, the prevailing macro-structural context is
clearly critical throughout the life course in the manifes-
tation of chronic disease, and increasingly so within the
developing world. As many18,217,218 have pointed out, it is
the macro-economic and political context that determines
the resources available to different groups, the resources
necessary for opting for healthy or unhealthy lifestyles, the
exposure to risk factors, the nature and extent of
advertising, the social meaning that risk factors have for
different populations, and the political will, and societal
support for reducing the prevalence of risk factors.
A commentary by Kramer219 suggested that the rising
CHD prevalence in developing countries is largely
explicable by adult-level risk factors with little room
available for independent contributions from restricted
fetal growth. He clarifies that this is not to imply there is no
true (causal) effect of fetal growth on subsequent CHD,
but to suggest it is dwarfed by adult lifestyle factors, such
as diet, physical activity and smoking219. Others such as
Harding20 conclude that altered fetal nutrition influences
both fetal growth and later disease risk. However,
Marmot149 has emphasized the influences of both, and
sees an unnecessary dichotomy in the argument. Growth
factors associated with growth in utero or the first year of
life, and contemporaneous influences, are certainly both
important, and conditions throughout life determine social
inequalities in adult disease. In the recent review
document on programming of chronic disease by
impaired fetal nutrition14, Delisle concluded that ‘preven-
tion of impaired fetal growth through improved nutrition
of girls and women not only contributes to lower maternal
mortality, and better child survival and development, it
may also help to prevent chronic disease, and in particular,
the obesity, diabetes and cardiovascular disease epidemic
in developing countries’.
The prevention and control of chronic diseases should
be intimately integrated into normal daily life to be
sustainable. How this is to be done will vary according to
culture, life stage and socioeconomic context. It is clear
that disease promoting and inhibiting factors are operating
throughout the life course, not least during the antenatal
period. Therefore, strategies to address the major risk
factors of unhealthy diet, physical inactivity and smoking
must also take into account the underlying economic,
gender, political, behavioural and environmental factors
that foster these disease risks (Fig. 3). Furthermore,
strategies must take into account the varied ways in which
urbanization and globalization can predispose to risk
behaviours and factors in different socioeconomic con-
texts and populations. Particular attention should also be
paid to primary prevention strategies, including those well
‘up-stream’, to counter the emergence of risk factors and
behaviours in childhood and adolescence, especially in
developing countries.
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As the causes, stresses and changing lifestyles and
environments leading to the current global epidemic act
on people throughout the life course—from fetus to oldest
age—so must prevention and control. Three mutually
reinforcing strategies, that will have different magnitudes
of impact over differing time frames, are therefore
suggested as necessary and mutually reinforcing.
Firstly, and with greatest and most immediate impact is
to address risk factors in adulthood, and increasingly, the
elderly. Risk factor behaviours can be modified in these
groups and changes seen within 3–5 years. With all
populations ageing, the sheer numbers and potential cost
savings are enormous and realizable. Much more effort
needs to be made to make the positive experiences seen in
Australia, Europe, and North America accessible to those
less enabled to take advantage of the experience.
Secondly, the limited success with societal change
needs to be greatly expanded as an integral part of any
intervention. Ways that reduce the intake of soft drinks,
cigarette smoking and high-energy diets, and increase
physical activity will have an impact throughout society.
Properly addressed, such social, cultural and political
change will produce an environment in which those more
disadvantaged and less empowered to make behavioural
change will live in societies in which such change is made
easier, and where healthier options are the norm. Such
change, already happening in many cities and towns,
needs the active, and sometimes coerced and encouraged,
participation of communities, politicians, health systems,
town planners and municipalities and the food and leisure
industries.
Thirdly, is a more targeted, and potentially more costly
approach, but with likely cost-effective returns. This
approach is even longer term than that above, and again
aims to change the health environment in which those
most at risk, grow up. This specifically acknowledges that
the greatest burden of disease will be in the developing
world and in the transitional and in the industrialized
world, amongst the most disadvantaged socioeconomi-
cally. This approach needs to actively target those most
vulnerable, such that along with the changes outlined
above, adolescent girls do not get pregnant, and if they do,
their nutritional status is such that the infant does not come
from an intra-uterine environment that leads to a low birth
weight and emerges into a disadvantaged environment
hostile to its development and health.
The three approaches address the most numerous and
the most vulnerable, but also those who have some
influence on society. It might appear optimistic, but we
have seen that there is enough information, and enough
successful programmes around, to suggest it is possible. If
not, the looming greatest burden of disease in both the
industrialized and developing worlds will become the
longest running and most destructive epidemic since that
of the on-going undernutrition of the world’s poorest
children. Given both epidemics affect those most
vulnerable, the two are intimately linked, both in causing
disease, and how they must be addressed.
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